Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Choice Hotels
CHH
$4.66B
| $406K | ﹤0.01% |
3,926
+685
| +21% | +$71.2K |
2020 Q2
23 quarters
|
|
1102
DELISTED
Amicus Therapeutics
FOLD
| $406K | ﹤0.01% |
28,053
+4,521
| +19% | +$64.8K |
2021 Q2
19 quarters
|
|
1103
Core Scientific
CORZ
$4.34B
| $405K | ﹤0.01% |
27,087
+4,191
| +18% | +$71.5K |
2024 Q2
7 quarters
|
|
1104
DELISTED
Arcellx
ACLX
| $405K | ﹤0.01% |
+3,524
| New | +$311K |
2026 Q1
0 quarters
|
|
1105
IES Holdings
IESC
$11.3B
| $405K | ﹤0.01% |
1,698
+266
| +19% | +$61K |
2025 Q2
3 quarters
|
|
1106
Riot Platforms
RIOT
$5.67B
| $404K | ﹤0.01% |
32,680
+5,214
| +19% | +$80K |
2023 Q4
9 quarters
|
|
1107
Eastern Bankshares
EBC
$4.76B
| $404K | ﹤0.01% |
20,644
+3,132
| +18% | +$62.5K |
2024 Q3
6 quarters
|
|
1108
AAR Corp
AIR
$3.9B
| $402K | ﹤0.01% |
3,675
+621
| +20% | +$66.8K |
2025 Q3
2 quarters
|
|
1109
CRISPR Therapeutics
CRSP
$4.86B
| $401K | ﹤0.01% |
8,436
+1,524
| +22% | +$80.4K |
2025 Q2
3 quarters
|
|
1110
Itron
ITRI
$3.7B
| $401K | ﹤0.01% |
4,473
+596
| +15% | +$57.2K |
2023 Q4
9 quarters
|
|
1111
BILL Holdings
BILL
$3.77B
| $401K | ﹤0.01% |
10,463
+2,355
| +29% | +$105K |
2020 Q3
22 quarters
|
|
1112
Mueller Water Products
MWA
$3.38B
| $400K | ﹤0.01% |
14,554
+2,307
| +19% | +$63.9K |
2024 Q3
6 quarters
|
|
1113
ICICI Bank
IBN
$101B
| $400K | ﹤0.01% |
15,446
+4,175
| +37% | +$122K |
2025 Q1
4 quarters
|
|
1114
ACI Worldwide
ACIW
$5.16B
| $400K | ﹤0.01% |
9,751
+1,565
| +19% | +$65.7K |
2020 Q2
23 quarters
|
|
1115
White Mountains Insurance
WTM
$5.01B
| $400K | ﹤0.01% |
182
+59
| +48% | +$126K |
2024 Q4
5 quarters
|
|
1116
Avis
CAR
$3.77B
| $398K | ﹤0.01% |
2,731
+425
| +18% | +$48.5K |
2020 Q4
21 quarters
|
|
1117
Scholar Rock
SRRK
$4.82B
| $398K | ﹤0.01% |
8,091
+1,598
| +25% | +$71.6K |
2025 Q2
3 quarters
|
|
1118
Moelis & Co
MC
$4.02B
| $396K | ﹤0.01% |
6,945
+1,050
| +18% | +$68.3K |
2023 Q4
9 quarters
|
|
1119
OSI Systems
OSIS
$3.07B
| $396K | ﹤0.01% |
1,490
+208
| +16% | +$57.5K |
2025 Q1
4 quarters
|
|
1120
Loar Holdings
LOAR
$5.75B
| $395K | ﹤0.01% |
6,902
+913
| +15% | +$61.6K |
2024 Q4
5 quarters
|
|
1121
Brookdale Senior Living
BKD
$2.41B
| $395K | ﹤0.01% |
28,873
+10,626
| +58% | +$149K |
2022 Q2
15 quarters
|
|
1122
The Marzetti Company
MZTI
$2.76B
| $395K | ﹤0.01% |
2,854
+403
| +16% | +$64.1K |
2020 Q2
23 quarters
|
|
1123
Kyndryl
KD
$2.57B
| $394K | ﹤0.01% |
29,993
+6,484
| +28% | +$114K |
2021 Q4
17 quarters
|
|
1124
Champion Homes
SKY
$4.12B
| $393K | ﹤0.01% |
5,291
+821
| +18% | +$70.7K |
2023 Q1
12 quarters
|
|
1125
Telephone and Data Systems
TDS
$3.91B
| $393K | ﹤0.01% |
9,333
+1,442
| +18% | +$63.4K |
2024 Q4
5 quarters
|
|
Similar funds
NMO
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.